Boothbay Fund Management, LLC Verrica Pharmaceuticals Inc. Transaction History
Boothbay Fund Management, LLC
- $3.27 Billion
- Q4 2024
A detailed history of Boothbay Fund Management, LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 2,587,046 shares of VRCA stock, worth $20.6 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
2,587,046Holding current value
$20.6 Million% of portfolio
0.63%Shares
2 transactions
Others Institutions Holding VRCA
# of Institutions
79Shares Held
26.1MCall Options Held
9.9KPut Options Held
6.5K-
Armistice Capital, LLC New York, NY8.92MShares$70.9 Million1.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.25MShares$25.8 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$14.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
State Street Corp Boston, MA523KShares$4.16 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...